GPFT - InvestorNewsBreaks - Grapefruit USA Inc. (GPFT) Announces Health Canada Approval for Hourglass(TM) Time Release THC+CBD Delivery Cream
Grapefruit USA (OTCQB: GPFT), an innovative California-based cannabiotech company, has received approval from Health Canada for its Notice of New Cannabis Product (“NNCP”). GPFT filed the notice in January. Health Canada approval allows Grapefruit to sell its patented Hourglass Time Release THC+CBD infused Topical Delivery Cream to licensed retail outlets in Canada and California; according to the announcement, the potential market in those two locations is more than 75 million people. Grapefruit’s Hourglass THC/CBD delivery cream is designed to fundamentally change the way humans ingest THC, CBD and other cannabinoids, paving the way for consumers to experience benefits from the substances while avoiding dangerous exposure that comes from smoking and/or orally ingesting them. “Health Canada’s approval of our Hourglass THC/CBD/cannabinoid topical cream is an inflection point for us and establishes Grapefruit as one of the world’s leading multinational canna-biotechnology firms,” said Grapefruit CEO and cofounder Bradley J. Yourist in the press release. “The company will continue to emphasize utilizing our proprietary Hourglass technology to maximize the benefits of cannabinoids for our consumers while minimizing any negative side effects. Only Grapefruit and its authorized agents may manufacture, distribute or retail Hourglass technology-based products in the California and Canada markets, and no other cannabis products in the world measure up to Hourglass-based products. Sales of Hourglass-based products will commence in Canada as soon as possible. Furthermore, the company will be announcing further details of its previously announced acquisition of Diagnostic Lab Corporation in the near future.”
To view the full press release, visit https://ibn.fm/M9In9
About Grapefruit USA Inc.
Grapefruit's corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products in the Golden State. Grapefruit's extraction laboratory and manufacturing and distribution facilities are located in the industry-recognized Coachillin' Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, California. To find out more about the company, please visit https://GrapefruitBlvd.com.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.